O2 RegenTech

O2 RegenTech

Cost-effective, easy-to-use wound care solutions based on novel oxygenating biopolymer technology

Founded 2015 2 employees Seed Total: $960.00K

O2 RegenTech is a promising startup focusing on cost-effective, easy-to-use wound care solutions based on novel oxygenating biopolymer technology. Their slogan "Cost-effective, easy-to-use wound care solutions based on novel oxygenating biopolymer technology" encapsulates their core value proposition. Founded in 2015, the company has recently secured a $250.00K Seed Round investment on 30 July 2021, with Newchip Accelerator being the investors. O2 RegenTech's innovative platform biopolymer technology, OXAID™, aims to introduce the first product in the market that combines the advantages of delivering oxygen with a moist and antimicrobial healing environment, all packaged in a cost-effective and easy-to-use dressing to promote chronic wound healing. This positions the company uniquely in the niche, with a focus on addressing critical issues such as diabetes, wound healing, foot ulcers, chronic wounds, wound dressing, and oxygen. For potential investors seeking opportunities in the healthcare and biotechnology sectors, O2 RegenTech presents a compelling investment case with its innovative technology and recent funding round, making it a startup to watch in the coming years. Interested parties can explore investment opportunities further on Netcapital.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	••••••	1	•••• ••••	30 Jul 2021
Non Equity Assistance	••••••	1		21 Oct 2020
Pre Seed Round	••••••	1		15 Nov 2017
Grant	••••••	3	•••• ••••	26 Jan 2017
Pre Seed Round	••••••	2		10 Jun 2015

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

••••••

•••• ••••

30 Jul 2021

Non Equity Assistance

••••••

21 Oct 2020

Pre Seed Round

••••••

15 Nov 2017

Grant

••••••

•••• ••••

26 Jan 2017

Pre Seed Round

••••••

10 Jun 2015

FAQ About O2 RegenTech

Cost-effective, easy-to-use wound care solutions based on novel oxygenating biopolymer technology

O2 RegenTech was founded in 2015.

O2 RegenTech has approximately 2 employees.

O2 RegenTech has completed 5 funding rounds, raising a total of $960.00K. The latest funding stage is Seed.

Top alternatives and competitors to O2 RegenTech include ALTRAZEAL® Life Sciences Inc., ViOptix, Inc., Colzyx, NanoTess, Inochi Care. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

O2 RegenTech and ALTRAZEAL® Life Sciences Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Track O2 RegenTech

About O2 RegenTech

Funding Rounds & Investors (5)

O2 RegenTech Alternatives & Competitors

FAQ About O2 RegenTech

Don't just browse. Track.